Evidence map›Paper›PMID 40454182›Full record

ReviewJournal of diabetes and metabolic disorders2025

Non-blood type O is associated with an increased likelihood of gestational diabetes development: findings from an updated meta-analysis.

Raphael Enrique Tiongco, Miljun Catacata, Pia Vanessa Basilio, Eliezer John Castro, Benjie Clemente, Raenard Emmanuel Dayrit, Michelle Charina Gomez, Michael John Dominguez, Shamar Lo Lasta, Jefferyl Kae Pandac and 1 more

Abstract readReview
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Raphael Enrique TiongcoCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Miljun CatacataCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Pia Vanessa BasilioCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Eliezer John CastroCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Benjie ClementeDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Raenard Emmanuel DayritCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Michelle Charina GomezCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Michael John DominguezCollege of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.
Shamar Lo LastaInstitute of Clinical Laboratory Sciences, Silliman University, Dumaguete, Negros Oriental Philippines.
Jefferyl Kae PandacInstitute of Clinical Laboratory Sciences, Silliman University, Dumaguete, Negros Oriental Philippines.
Maria Ruth Pineda-CortelDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Several factors are attributed to the development of gestational diabetes mellitus (GDM), but its association with the ABO blood group is still unexplored. Hence, we performed a meta-analysis to examine this association. Methods: Relevant articles were obtained from various databases until April 5, 2025. All related data were extracted by two authors and summarized in a customized spreadsheet. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed and interpreted. Results: The pooled analysis showed homogeneity in the outcomes. Pooled ORs show that pregnant women with non-blood type O showed more significant associations than those with blood type O. Conclusion: Overall, the present meta-analysis suggests that individuals with non-blood type O have an increased risk of developing GDM compared to those with blood type O. However, further studies stratifying populations based on insulin resistance, gut microbiota, and inflammation in association with ABO and GDM development are needed to confirm these claims. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01653-1.

Indexed as

ABO blood groupGestational diabetesMeta-analysis

Identifiers

PMID40454182
PMCPMC12125415

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.